The optimal treatment of severe hypertension in pregnancy: Update of the role of nicardipine

Current Pharmaceutical Biotechnology

Volumn 15, Issue 1, 2014, Pages 64-69

  Nooij, Linda S ^a   Visser, Sanne ^b   Meuleman, Tess ^a   Vos, Paul ^a   Roelofs, Robin ^a   de Groot, Christianne J M ^b  

^a MCHaaglanden ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ketanserin; Labetalol; Nicardipine; Pre eclampsia; Pregnancy induced hypertension; Treatment

Indexed keywords

LABETALOL; NICARDIPINE; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MONITORING; FEMALE; FETUS DISTRESS; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PREECLAMPSIA; RESPIRATORY TRACT DISEASE; TACHYCARDIA; CHEMICALLY INDUCED; META ANALYSIS; NEWBORN; PREGNANCY;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; HYPOTENSION; INFANT, NEWBORN; LABETALOL; NICARDIPINE; PREGNANCY;

EID: 84904753601     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140330194722     Document Type: Article

References (30)

1. Elatrous, S.; Nouira, S.; Ouanes, B. L.; Marghli, S.; Boussarssar, M.; Sakkouhi, M.; Abroug, F. Short-term treatment of severe hypertension of pregnancy: Prospective comparison of nicardipine and labetalol. Intens. Care Med., 2002, 28, 1281-1286.
2. Sibai, B. M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet. Gynecol., 2003, 102, 181-192.
3. Koopmans, C. M.; Bijlenga, D.; Groen, H.; Vijgen, S. M.; Aarnoudse, J. G.; Bekedam, D. J.; van den Berg, P. P.; de, B. K.; Burggraaff, J. M.; Bloemenkamp, K. W.; Drogtrop, A. P.; Franx, A.; de Groot, C. J.; Huisjes, A. J.; Kwee, A.; van Loon, A. J.; Lub, A.; Papatsonis, D. N.; van der Post, J. A.; Roumen, F. J.; Scheepers, H. C.; Willekes, C.; Mol, B. W.; van Pampus, M. G. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): A multicentre, open-label randomised controlled trial. Lancet, 2009, 374, 979-988.
4. Schutte, J. M.; Steegers, E. A.; Schuitemaker, N. W.; Santema, J. G.; de, B. K.; Pel, M.; Vermeulen, G.; Visser, W.; van, R. J. Rise in maternal mortality in the Netherlands. BJOG., 2010, 117, 399-406.
5. Sibai, B.; Dekker, G.; Kupferminc, M. Pre-Eclampsia. Lancet 2005, 365, 785-799.
6. Hanff, L. M.; Visser, W.; Roofthooft, D. W.; Vermes, A.; Hop, W. C.; Steegers, E. A.; Vulto, A. G. Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 128, 199-203.
7. Sibai, B. M.; Mercer, B. M.; Schiff, E.; Friedman, S. A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 Weeks' Gestation: A randomized controlled trial. Am. J. Obstet. Gynecol., 1994, 171, 818-822.
8. Sibai, B. M. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/preeclampsia. Semin. Perinatol., 2011, 35, 292-296.
9. Sibai, B. M. Evaluation and management of severe preeclampsia before 34 Weeks' gestation. Am. J. Obstet. Gynecol., 2011, 205, 191-198.
10. Steegers, E. A.; von, D. P.; Duvekot, J. J.; Pijnenborg, R. Pre-Eclampsia. Lancet, 2010, 376, 631-644.
11. Vadhera, R. B.; Pacheco, L. D.; Hankins, G. D. Acute antihypertensive therapy in pregnancy-induced hypertension: is nicardipine the answer? Am. J. Perinatol., 2009, 26, 495-499.
12. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch. Intern. Med., 1993, 153, 154-183.
13. Martin, J. N. Jr.; Thigpen, B. D.; Moore, R. C.; Rose, C. H.; Cushman, J.; May, W. Stroke and severe preeclampsia and eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet. Gynecol., 2005, 105, 246-254.
14. Committee Opinion No. 514: Emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet. Gynecol., 2011, 118, 1465-1468.
15. Duley, L.; Meher, S.; Jones, L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst. Rev., 2013, 7, CD001449.
16. Kirkpatrick, D. H.; Burkman, R. T. Does standardization of care through clinical guidelines improve outcomes and reduce medical liability? Obstet. Gynecol., 2010, 116, 1022-1026.
17. Marik, P. E.; Varon, J. Hypertensive crises: Challenges and management. Chest, 2007, 131, 1949-1962.
18. Rogers, R. C.; Sibai, B. M.; Whybrew, W. D. Labetalol pharmacokinetics in pregnancy-induced hypertension. Am. J. Obstet. Gynecol., 1990, 162, 362-366.
19. Saotome, T.; Minoura, S.; Terashi, K.; Sato, T.; Echizen, H.; Ishizaki, T. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokineticdynamic analysis. J. Clin. Pharmacol., 1993, 33, 979-988.
20. Fischer, J. H.; Sarto, G. E.; Hardman, J.; Endres, L.; Jenkins, T. M.; Kilpatrick, S. J.; Jeong, H.; Geller, S.; Deyo, K.; Fischer, P. A.; Rodvold, K. A. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. Clin. Pharmacokinet., 2014, 53(4), 373-383.
21. McCoy, S.; Baldwin, K. Pharmacotherapeutic options for the treatment of preeclampsia. Am. J. Health Syst. Pharm., 2009, 66, 337-344.
22. Hanff, L. M.; Vulto, A. G.; Bartels, P. A.; Roofthooft, D. W.; Bijvank, B. N.; Steegers, E. A.; Visser, W. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients. J. Hypertens., 2005, 23, 2319-2326.
23. Wallin, J. D.; Cook, M. E.; Blanski, L.; Bienvenu, G. S.; Clifton, G. G.; Langford, H.; Turlapaty, P.; Laddu, A. Intravenous nicardipine for the treatment of severe hypertension. Am. J. Med., 1988, 85, 331-338.
24. Bartels, P. A.; Hanff, L. M.; Mathot, R. A.; Steegers, E. A.; Vulto, A. G.; Visser, W. Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk. BJOG, 2007, 114, 230-233.
25. Seki, H.; Takeda, S.; Kinoshita, K. Long-term treatment with nicardipine for severe pre-eclampsia. Int. J. Gynaecol. Obstet., 2002, 76, 135-141.
26. Aya, A. G.; Mangin, R.; Hoffet, M.; Eledjam, J. J. Intravenous nicardipine for severe hypertension in pre-eclampsia--effects of an acute treatment on mother and foetus. Intens. Care Med., 1999, 25, 1277-1281.
27. Matsumura, H.; Takagi, K.; Seki, H.; Ono, Y.; Ichinose, S.; Masuko, H.; Fukatsu, M.; Miyashita, A.; Mera, A. Placental transfer of intravenous nicardipine and disposition into breast milk during the control of hypertension in women with pre-eclampsia. hypertens. Pregnancy, 2014, 33, 93-101.
28. Nij Bijvank, S. W.; Duvekot, J. J. Nicardipine for the treatment of severe hypertension in pregnancy: A review of the literature. Obstet. Gynecol. Surv., 2010, 65, 341-347.
29. Carbonne, B.; Jannet, D.; Touboul, C.; Khelifati, Y.; Milliez, J. Nicardipine treatment of hypertension during pregnancy. Obstet. Gynecol., 1993, 81, 908-914.
30. Raheem, I. A.; Saaid, R.; Omar, S. Z.; Tan, P. C. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: A randomised trial. BJOG, 2012, 119, 78-85.